Workforce woes: India's Infra boom strains under blue-collar shortage
Mon, Feb 12, 2024 2:57 PM

Workforce woes: India's Infra boom strains under blue-collar shortage

A Flip by Avya Verma
Get it on Google Play
India is facing a growing need for blue-collar workers in the infrastructure and manufacturing sectors due to increased government spending and growth in these industries. However, there seems to be a mismatch between where these jobs are located and where the talent pool is located, as well as a preference among candidates to work in their home state.

More great flips

DIIs net bought shares worth Rs 2,174 crore, FIIs net sold Rs 1,893 crore

DIIs net bought shares worth Rs 2,174 crore, FIIs net sold Rs 1,893 crore

On December 30, domestic institutional investors (DIIs) net bought shares worth Rs 2,174 crore crore, while foreign institutional investors (FIIs) net sold shares worth Rs 1,893 crore, provisional data from NSE showed. During the trading session, DIIs bought Rs 41,787 crore and sold shares worth Rs 39,613 crore, and FIIs purchased Rs 15,508 crore in shares.

Open Flip
Govt to adopt new approach to track cost overruns: Sources

Govt to adopt new approach to track cost overruns: Sources

The Indian government will launch a new system in January 2025 to track cost overruns in projects, making the process more standardised, with reforms to the Online Computerised Monitoring System and integration with other government initiatives. The move aims to better track outcomes and address cost overruns, which currently stand at nearly 20% of the original cost.

Open Flip
Lupin acquires Huminsulin from Eli Lilly to enhance diabetes care portfolio

Lupin acquires Huminsulin from Eli Lilly to enhance diabetes care portfolio

Pharma major Lupin has acquired Huminsulin brand in India from Eli Lilly, in an effort to enhance its diabetes portfolio, the company said in an exchange filing on December 30.Lupin had been marketing Huminsulin through an existing agreement with Lilly India before proceeding to acquire the brand. The drug is used in the treatment of Type 1 and Type 2 diabetes mellitus.

Open Flip

Join our Smart Investment Community

More than 2 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon